Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Capital Group Growth ETF
CGGR
$25.1B
| $905K | ﹤0.01% |
26,000
-14,000
| -35% | -$464K |
|
2502
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $904K | ﹤0.01% |
30,100
+16,700
| +125% | +$492K |
|
2503
IBEX
IBEX
$495M
| $903K | ﹤0.01% |
45,200
+16,400
| +57% | +$282K |
|
2504
Magnachip Semiconductor
MX
$141M
| $903K | ﹤0.01% |
+193,354
| New | +$940K |
|
2505
Yatra Online
YTRA
$55.8M
| $902K | ﹤0.01% |
529,236
-17,900
| -3% | -$25.2K |
|
2506
Lesaka Technologies
LSAK
$403M
| $901K | ﹤0.01% |
180,219
-1,881
| -1% | -$8.92K |
|
2507
AudioEye
AEYE
$72.2M
| $900K | ﹤0.01% |
39,400
-21,100
| -35% | -$464K |
|
2508
BioAtla
BCAB
$5.53M
| $900K | ﹤0.01% |
10,228
-2,282
| -18% | -$191K |
|
2509
First Trust Rising Dividend Achievers ETF
RDVY
$25.5B
| $900K | ﹤0.01% |
15,200
+2,200
| +17% | +$125K |
|
2510
Liberty Energy
LBRT
$3.27B
| $899K | ﹤0.01% |
+47,100
| New | +$972K |
|
2511
AMES National
ATLO
$278M
| $898K | ﹤0.01% |
49,284
-200
| -0.4% | -$3.85K |
|
2512
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
| $898K | ﹤0.01% |
10,100
+5,900
| +140% | +$510K |
|
2513
Origin Bancorp
OBK
$1.67B
| $897K | ﹤0.01% |
27,900
-2,800
| -9% | -$91.2K |
|
|
DDI
2514
DoubleDown Interactive
DDI
$590M
| $897K | ﹤0.01% |
54,378
+13,878
| +34% | +$181K |
|
2515
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
| $894K | ﹤0.01% |
35,000
+12,300
| +54% | +$310K |
|
2516
Choiceone Financial
COFS
$514M
| $893K | ﹤0.01% |
28,900
+9,900
| +52% | +$284K |
|
2517
Gaia
GAIA
$48.1M
| $891K | ﹤0.01% |
183,040
-37,426
| -17% | -$175K |
|
2518
Destination XL Group
DXLG
$32.6M
| $886K | ﹤0.01% |
301,300
-61,600
| -17% | -$192K |
|
|
BLFY
2519
DELISTED
Blue Foundry Bancorp
BLFY
| $885K | ﹤0.01% |
86,300
+38,600
| +81% | +$401K |
|
|
MRNS
2520
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $883K | ﹤0.01% |
501,931
-119,694
| -19% | -$167K |
|
2521
Legend Biotech
LEGN
$3.73B
| $882K | ﹤0.01% |
+18,100
| New | +$964K |
|
2522
Horizon Bancorp
HBNC
$1.05B
| $882K | ﹤0.01% |
56,716
+744
| +1% | +$11.1K |
|
2523
Ramaco Resources Class B
METCB
$384M
| $881K | ﹤0.01% |
88,344
+17,259
| +24% | +$173K |
|
2524
Fidelity MSCI Health Care Index ETF
FHLC
$3.33B
| $881K | ﹤0.01% |
+12,100
| New | +$866K |
|
2525
Amylyx Pharmaceuticals
AMLX
$2.7B
| $881K | ﹤0.01% |
271,800
-539,688
| -67% | -$1.21M |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.